Peter Johnson, M.D.


Peter C. Johnson, M.D. is a University of Notre Dame and SUNY Upstate Medical University graduate. After General and Plastic Surgery training, Dr. Johnson practiced reconstructive surgery for ten years at U. Pittsburgh where he founded and was the first President of the Pittsburgh Tissue Engineering Initiative.

Subsequent roles were co-founder/CEO of Tissue Informatics, EVP of Life Sciences, CMO and CBO of Icoria, EVP, Entegrion, Inc. and VP, Research and Development and Medical and Scientific Affairs of Vancive Medical Technologies, an Avery Dennison business. He presently serves as President and CEO of Scintellix, LLC and Chief Medical Advisor to Vancive Medical Technologies.

He has chaired the Plastic Surgery Research Council, was President of the Pennsylvania Biotechnology Association and the Tissue Engineering Society, International (now TERMIS) and is presently the Co-Editor-in-Chief of the three-part Journal, Tissue Engineering. He serves on the Industry Committee of the Tissue Engineering and Regenerative Medicine International Society (TERMIS), is on the board of the Transverse Myelitis Association and is on the Industry Advisory Board of the UNC/NC State Joint Program in Bioengineering.

He is an Adjunct Professor of Surgery, Bioengineering and Business at the University of North Carolina at Chapel Hill, of Bioengineering at NC State and of Regenerative Medicine at Wake Forest University School of Medicine. He is an avid cook; fly fisherman, artist and novelist.

Peter Johnson, M.D.

Co-Founder, Pittsburgh Tissue Engineering Initiative University of Pittsburgh Medical Center


BA, University of Notre Dame;

MD, SUNY Upstate Medical University